These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35339512)

  • 21. Forearm vasoconstriction to endothelin-1 is impaired, but constriction to sarafotoxin 6c and vasodilatation to BQ-123 unaltered, in patients with essential hypertension.
    Ferro CJ; Haynes WG; Hand MF; Webb DJ
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():53S-58S. PubMed ID: 12193054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelin-1 (ET-1)-potentiated insulin secretion: involvement of protein kinase C and the ET(A) receptor subtype.
    Gregersen S; Thomsen JL; Hermansen K
    Metabolism; 2000 Feb; 49(2):264-9. PubMed ID: 10690956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelin in atherosclerosis: importance of risk factors and therapeutic implications.
    d'Uscio LV; Barton M; Shaw S; Lüscher TF
    J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S55-59. PubMed ID: 10976783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular and renal actions of the endothelin(B) receptor in pigs.
    Cirino M; Martin E; Yano M; Rodger IW
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):704-12. PubMed ID: 9234650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The endothelin system in pulmonary arterial hypertension.
    Galié N; Manes A; Branzi A
    Cardiovasc Res; 2004 Feb; 61(2):227-37. PubMed ID: 14736539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelin B receptors located on the endothelium provide cardiovascular protection in the hamster.
    Honoré JC; Proteau C; D'orléans-Juste P
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():280S-283S. PubMed ID: 12193104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective ET(A) receptor antagonism with ABT-627 attenuates all renal effects of endothelin in humans.
    Honing MLH; Hijmering ML; Ballard DE; Yang YP; Padley RJ; Morrison PJ; Rabelink TJ
    J Am Soc Nephrol; 2000 Aug; 11(8):1498-1504. PubMed ID: 10906163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New expansion of endothelin research: perspectives for clinical application of endothelin-receptor antagonists].
    Goto K; Miyauchi T
    Nihon Yakurigaku Zasshi; 2003 Feb; 121(2):91-101. PubMed ID: 12616854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced endothelin(A) receptor-mediated calcium mobilization and contraction in organ cultured porcine coronary arteries.
    Hill BJ; Katwa LC; Wamhoff BR; Sturek M
    J Pharmacol Exp Ther; 2000 Nov; 295(2):484-91. PubMed ID: 11046079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelin-1 induced bronchial hyperresponsiveness in the rabbit: an ET(A) receptor-mediated phenomenon.
    D'Agostino B; Gallelli L; Falciani M; Di Pierro P; Rossi F; Filippelli A; Rossi F
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec; 360(6):665-9. PubMed ID: 10619183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelin in cardiovascular control: the role of endothelin antagonists.
    Wenzel RR; Czyborra P; Lüscher T; Philipp T
    Curr Hypertens Rep; 1999; 1(1):79-87. PubMed ID: 10981046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelin receptor antagonists and their developing role in cardiovascular therapeutics.
    Dupuis J
    Can J Cardiol; 2000 Jul; 16(7):903-10. PubMed ID: 10934309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of endothelin receptor antagonists on endothelin-1 and inducible nitric oxide synthase genes in a rat endotoxic shock model.
    Hirata Y; Ishimaru S
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():332S-335S. PubMed ID: 12193116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of functional endothelin receptors in the porcine myometrium.
    Isaka M; Takaoka K; Yamada Y; Abe Y; Kitazawa T; Taneike T
    Peptides; 2000 Apr; 21(4):543-51. PubMed ID: 10822110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of ET(A) receptors in the vasoconstriction induced by endothelin-1 in subcutaneous small arteries of normotensive subjects and hypertensive patients.
    Porteri E; Rizzoni D; Guelfi D; De CC; Castellano M; Bettoni G; Tiberio GA; Giulini SM; Sleiman I; Agabiti-Rosei E
    Blood Press; 2002; 11(1):6-12. PubMed ID: 11930911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats.
    Johnson RJ; Fink GD; Watts SW; Galligan JJ
    J Hypertens; 2002 Apr; 20(4):665-76. PubMed ID: 11910302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemodynamic influence and endothelin-1 plasma concentrations by selective or non-selective endothelin receptor antagonists in the pig in vivo.
    Holm P; Franco-Cereceda A
    Acta Physiol Scand; 1999 Feb; 165(2):163-8. PubMed ID: 10090327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The discovery of endothelium-dependent contraction: the legacy of Paul M. Vanhoutte.
    Barton M
    Pharmacol Res; 2011 Jun; 63(6):455-62. PubMed ID: 21385610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of endothelin-1 for microvascular dysfunction in diabetes.
    Kalani M
    Vasc Health Risk Manag; 2008; 4(5):1061-8. PubMed ID: 19183753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of endothelin antagonists, including the novel ET(A) receptor antagonist LBL 031, on endothelin-1 and lipopolysaccharide-induced microvascular leakage in rat airways.
    Hele DJ; Birrell MA; Webber SE; Foster ML; Belvisi MG
    Br J Pharmacol; 2000 Nov; 131(6):1129-34. PubMed ID: 11082120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.